审核通过！奥浦迈或成“并购六条”首单分期股权支付重组

Core Viewpoint - Aopu Mai's asset acquisition plan has been approved by the Shanghai Stock Exchange's M&A Committee, marking it as the first case in the A-share market to utilize a "staged payment mechanism" for share consideration since the release of the "Six M&A Rules" [1][2] Group 1: Company Overview - Aopu Mai, listed on the Sci-Tech Innovation Board in 2022, focuses on the research and production of cell culture media and provides contract development and manufacturing organization (CDMO) services [1] - The target company, Pengli Bio, specializes in drug and medical device research and preclinical research services (CRO), recognized as a national-level specialized and innovative small giant and a high-tech enterprise [1] Group 2: Strategic Rationale - Both companies operate within the pharmaceutical research and production service sector, indicating significant synergy and complementary industrial advantages [1] - The merger aims to create an integrated service platform combining "culture media + CRO + CDMO," which is expected to meet clients' needs from early research to commercial production, enhancing one-stop service capabilities and integrated competitive levels [1] Group 3: Financial Data - As of the end of 2024, Aopu Mai's total assets are 2.272 billion yuan, with annual revenue and net profit attributable to shareholders at 297 million yuan and 21.0523 million yuan, respectively [2] - Pengli Bio's total assets are 1.216 billion yuan, exceeding Aopu Mai's total assets by 50%, with annual revenue and net profit at 330 million yuan and 45.15 million yuan, respectively, both surpassing Aopu Mai's figures [2] Group 4: Regulatory Context - The asset restructuring plan was likely to be classified as a "restructuring listing" prior to the release of the "Six M&A Rules," which would have subjected it to stricter scrutiny and a slower process [2] - The approval of Aopu Mai's restructuring project is seen as a typical case of implementing the "Six M&A Rules," aligning with the need for new productive forces and enhancing the resource allocation function of mergers and acquisitions [2]